These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16700816)

  • 1. Effect of rifampicin on the pharmacokinetics of atenolol.
    Lilja JJ; Juntti-Patinen L; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):555-8. PubMed ID: 16700816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of itraconazole on the pharmacokinetics of atenolol.
    Lilja JJ; Backman JT; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
    Lilja JJ; Backman JT; Laitila J; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Mar; 73(3):192-8. PubMed ID: 12621384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
    Villikka K; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of orange juice on the pharmacokinetics of atenolol.
    Lilja JJ; Raaska K; Neuvonen PJ
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):337-40. PubMed ID: 15983823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin reduces plasma concentrations of celiprolol.
    Lilja JJ; Niemi M; Neuvonen PJ
    Eur J Clin Pharmacol; 2004 Jan; 59(11):819-24. PubMed ID: 14614579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
    Kyrklund C; Backman JT; Kivistö KT; Neuvonen M; Laitila J; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
    Backman JT; Luurila H; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone.
    Niemi M; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Sep; 76(3):239-49. PubMed ID: 15371985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol.
    Lilja JJ; Juntti-Patinen L; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Mar; 75(3):184-90. PubMed ID: 15001969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
    Park JY; Kim KA; Park PW; Park CW; Shin JG
    Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic interaction of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers.
    Misaka S; Miyazaki N; Yatabe MS; Ono T; Shikama Y; Fukushima T; Kimura J
    J Clin Pharmacol; 2013 Jul; 53(7):738-45. PubMed ID: 23677858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of atenolol enantiomers in 12 Chinese healthy men.
    Wang XM; Yu XY; Lin SG
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):367-70. PubMed ID: 10452127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
    Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
    Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic evaluation of atenolol during and after pregnancy.
    Hurst AK; Shotan A; Hoffman K; Johnson J; Goodwin TM; Koda R; Elkayam U
    Pharmacotherapy; 1998; 18(4):840-6. PubMed ID: 9692658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.
    Han Y; Guo D; Chen Y; Tan ZR; Zhou HH
    Xenobiotica; 2009 Sep; 39(9):694-9. PubMed ID: 19555315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical evaluation of oral tablet Atenolol (100 and 50 mg) on local population.
    Ali O; Obaid R; Saify ZS; Ahmed SW
    Pak J Pharm Sci; 2005 Jan; 18(1):25-32. PubMed ID: 16431379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.